Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

CKS Updates - November 2020

During November 2020 Clinical Knowledge Summaries were updated in the following areas.

All of the topics have been reviewed and updated in keeping with current NICE guidance with minor layout changes. The Menopause topic now includes a lower age range of 35 to include the diagnosis and management of suspected premature ovarian insufficiency. Additional options for non-hormonal therapy for the management of vasomotor symptoms are included and further information for women with hypothyroidism has been added to the section on managing co-morbidities.

Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.

Share 'CKS Updates - November 2020' on Email Share 'CKS Updates - November 2020' on Delicious Share 'CKS Updates - November 2020' on Digg Share 'CKS Updates - November 2020' on Facebook Share 'CKS Updates - November 2020' on reddit Share 'CKS Updates - November 2020' on Twitter

NICE Guidance - November 2020

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of November 2020. This month is one guideline and one medtech innovation briefing that impact upon primary care.

The Human and animal bites: antimicrobial prescribing guideline has been published. It sets out an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over. It aims to optimise antibiotic use and reduce antibiotic resistance.

The Dexcom G6 for real-time continuous glucose monitoring medtech innovation briefing has been published. This briefing notes that the intended place in therapy is as an alternative to routine blood glucose monitoring in people (over 2 years old), including pregnant women, with type 1 or type 2 diabetes, who use multiple daily insulin injections or use insulin pumps and are self-managing their diabetes. The available evidence notes that this device reduces interstitial fluid glucose levels and the time spent in hypoglycaemia compared with self-monitoring of blood glucose using finger-prick testing. It is noted that lifetime costs for this device are likely to be higher compared to finger-prick testing but this may be balanced by avoiding the costs associated with short-term and long-term clinical outcomes of poorly managed diabetes.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'NICE Guidance - November 2020' on Email Share 'NICE Guidance - November 2020' on Delicious Share 'NICE Guidance - November 2020' on Digg Share 'NICE Guidance - November 2020' on Facebook Share 'NICE Guidance - November 2020' on reddit Share 'NICE Guidance - November 2020' on Twitter

CKS Updates - October 2020

During October 2020 Clinical Knowledge Summaries were updated in the following areas.

All of the topics have been reviewed and updated in keeping with current NICE guidance with minor layout changes. The Gastroenteritis topic has undergone major restructuring, with several nodes merged to improve clarity and navigation.

Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.

Share 'CKS Updates - October 2020' on Email Share 'CKS Updates - October 2020' on Delicious Share 'CKS Updates - October 2020' on Digg Share 'CKS Updates - October 2020' on Facebook Share 'CKS Updates - October 2020' on reddit Share 'CKS Updates - October 2020' on Twitter

NICE Guidance - October 2020

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of October 2020. This month there are three guidelines, one technology appraisal and one antimicrobial guideline that impact upon primary care.

The COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community guideline has been updated. It aims to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection. The updated has amended recommendations on taking into account a patient’s existing medicines with reference to the MHRA advice on warfarin and other anticoagulants.

The Rheumatoid arthritis in adults: management guideline has been updated. It covers diagnosing and managing rheumatoid arthritis. It aims to improve quality of life by ensuring that people with rheumatoid arthritis have the right treatment to slow the progression of their condition and control their symptoms. This update amended the 'treat to target' recommendations to clarify that multiple disease-modifying anti-rheumatic drugs can be offered one after the other to achieve treatment targets.

The Behaviour change: digital and mobile health interventions guideline has been published. It covers interventions that use a digital or mobile platform to help people eat more healthily, become more active, stop smoking, reduce their alcohol intake or practise safer sex. The interventions include those delivered by text message, apps, wearable devices or the internet. The guideline only includes those that are delivered by the technology itself and not by healthcare professionals using technology to deliver interventions.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'NICE Guidance - October 2020' on Email Share 'NICE Guidance - October 2020' on Delicious Share 'NICE Guidance - October 2020' on Digg Share 'NICE Guidance - October 2020' on Facebook Share 'NICE Guidance - October 2020' on reddit Share 'NICE Guidance - October 2020' on Twitter

CKS Updates - September 2020

During September 2020 Clinical Knowledge Summaries were updated in the following areas.

All of the topics have been reviewed and updated in keeping with current NICE guidance.

Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.

Share 'CKS Updates - September 2020' on Email Share 'CKS Updates - September 2020' on Delicious Share 'CKS Updates - September 2020' on Digg Share 'CKS Updates - September 2020' on Facebook Share 'CKS Updates - September 2020' on reddit Share 'CKS Updates - September 2020' on Twitter

« Older Posts

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

vipers